| pubmed-article:12211578 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12211578 | lifeskim:mentions | umls-concept:C0019196 | lld:lifeskim |
| pubmed-article:12211578 | lifeskim:mentions | umls-concept:C0733511 | lld:lifeskim |
| pubmed-article:12211578 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
| pubmed-article:12211578 | lifeskim:mentions | umls-concept:C0032356 | lld:lifeskim |
| pubmed-article:12211578 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:12211578 | pubmed:dateCreated | 2002-9-4 | lld:pubmed |
| pubmed-article:12211578 | pubmed:abstractText | The aim was to evaluate hepatitis C surveillance in Poland during 1998. Hepatitis C reports were obtained from epidemiology offices. Public health staff were interviewed to collect information on surveillance operations. To estimate the proportion of acute cases among the total reported, a study was conducted in the Warsaw district to validate case reports. A total of 1661 (97.2%) hepatitis C cases were studied. Hepatitis C surveillance was timely and acceptable to the user, but did not provide a number of information elements required to differentiate acute from chronic cases of infection. Of the 268 case reports available in the Warsaw district, only 15 (5.6%) met the acute hepatitis C case definition. It is concluded that hepatitis C surveillance in Poland cannot provide useful incidence estimates and information regarding risk factors for acute infection. A strict case definition and a modified case form with specific questions for HCV transmission routes should be applied. | lld:pubmed |
| pubmed-article:12211578 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12211578 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12211578 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12211578 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12211578 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12211578 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12211578 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:12211578 | pubmed:issn | 0950-2688 | lld:pubmed |
| pubmed-article:12211578 | pubmed:author | pubmed-author:MorseD LDL | lld:pubmed |
| pubmed-article:12211578 | pubmed:author | pubmed-author:MazurekJJ | lld:pubmed |
| pubmed-article:12211578 | pubmed:author | pubmed-author:RADZINSKIJ... | lld:pubmed |
| pubmed-article:12211578 | pubmed:author | pubmed-author:HutinYY | lld:pubmed |
| pubmed-article:12211578 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12211578 | pubmed:volume | 129 | lld:pubmed |
| pubmed-article:12211578 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12211578 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12211578 | pubmed:pagination | 119-25 | lld:pubmed |
| pubmed-article:12211578 | pubmed:dateRevised | 2010-5-17 | lld:pubmed |
| pubmed-article:12211578 | pubmed:meshHeading | pubmed-meshheading:12211578... | lld:pubmed |
| pubmed-article:12211578 | pubmed:meshHeading | pubmed-meshheading:12211578... | lld:pubmed |
| pubmed-article:12211578 | pubmed:meshHeading | pubmed-meshheading:12211578... | lld:pubmed |
| pubmed-article:12211578 | pubmed:meshHeading | pubmed-meshheading:12211578... | lld:pubmed |
| pubmed-article:12211578 | pubmed:meshHeading | pubmed-meshheading:12211578... | lld:pubmed |
| pubmed-article:12211578 | pubmed:meshHeading | pubmed-meshheading:12211578... | lld:pubmed |
| pubmed-article:12211578 | pubmed:meshHeading | pubmed-meshheading:12211578... | lld:pubmed |
| pubmed-article:12211578 | pubmed:meshHeading | pubmed-meshheading:12211578... | lld:pubmed |
| pubmed-article:12211578 | pubmed:meshHeading | pubmed-meshheading:12211578... | lld:pubmed |
| pubmed-article:12211578 | pubmed:meshHeading | pubmed-meshheading:12211578... | lld:pubmed |
| pubmed-article:12211578 | pubmed:meshHeading | pubmed-meshheading:12211578... | lld:pubmed |
| pubmed-article:12211578 | pubmed:meshHeading | pubmed-meshheading:12211578... | lld:pubmed |
| pubmed-article:12211578 | pubmed:meshHeading | pubmed-meshheading:12211578... | lld:pubmed |
| pubmed-article:12211578 | pubmed:meshHeading | pubmed-meshheading:12211578... | lld:pubmed |
| pubmed-article:12211578 | pubmed:meshHeading | pubmed-meshheading:12211578... | lld:pubmed |
| pubmed-article:12211578 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:12211578 | pubmed:articleTitle | Evaluation of hepatitis C surveillance in Poland in 1998. | lld:pubmed |
| pubmed-article:12211578 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12211578 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12211578 | lld:pubmed |
